Emerald Mutual Fund Advisers Trust’s Alder Biopharmaceuticals ALDR Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,183,835	Closed	-$18.7M	–	265
2018 Q2	$18.7M	Sell	1,183,835 -162,214	-12%	-$2.46M	0.68%	47
2018 Q1	$17.1M	Sell	1,346,049 -100,816	-7%	-$1.46M	0.67%	49
2017 Q4	$16.6M	Buy	1,446,865 +176,310	+14%	+$1.97M	0.66%	52
2017 Q3	$15.6M	Buy	1,270,555 +327,846	+35%	+$3.42M	0.65%	53
2017 Q2	$10.8M	Buy	942,709 +524,746	+126%	+$9.7M	0.47%	75
2017 Q1	$8.69M	Hold	417,963	–	–	0.4%	92
2016 Q4	$8.69M	Buy	417,963 +33,826	+9%	+$880K	0.41%	86
2016 Q3	$12.6M	Buy	384,137 +144,248	+60%	+$4.39M	0.64%	62
2016 Q2	$5.99M	Buy	+239,889	New	+$6.49M	0.34%	108

Other funds holding ALDR

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ALDR Position: Q3 2018 in Review

Emerald Mutual Fund Advisers Trust sold out of Alder Biopharmaceuticals (ALDR) in Q3 2018, closing a stake of 1,183,835 shares — an estimated $18.7M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ALDR in Q2 2016 and held it in 9 quarters. The position peaked at $18.7M in Q2 2018. 128 funds tracked by Wall St. Rank hold ALDR as of Q3 2018.

Emerald Mutual Fund Advisers Trust reported no remaining Alder Biopharmaceuticals position as of Q3 2018 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 1,183,835 Alder Biopharmaceuticals shares in Q3 2018, an estimated $18.7M.
Emerald Mutual Fund Advisers Trust first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 9 quarters.
Emerald Mutual Fund Advisers Trust's Alder Biopharmaceuticals position peaked at $18.7M in Q2 2018.
128 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2018.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2018, filed 31 Oct 2018.